Sabby Management’s AIM ImmunoTech AIM Stock Holding History

Sabby Management’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-28,884	Closed	-$79.1K	–	52
2025 Q3	$79.1K	Buy	+28,884	New	+$129K	0.09%	30
2020 Q1	–	Sell	-5,293	Closed	-$288K	–	117
2019 Q4	$288K	Buy	5,293 +3,439	+185%	+$173K	0.08%	42
2019 Q3	$141K	Buy	1,854 +1,245	+204%	+$301K	0.08%	70
2019 Q2	$267K	Buy	+609	New	+$368K	0.34%	50
2018 Q4	–	Sell	-260	Closed	-$263K	–	160
2018 Q3	$263K	Sell	260 -181	-41%	-$221K	0.03%	89
2018 Q2	$620K	Buy	+441	New	+$645K	0.1%	77
2017 Q3	–	Sell	-214	Closed	-$472K	–	250
2017 Q2	$472K	Sell	214 -52	-20%	-$129K	0.03%	144
2017 Q1	$638K	Sell	266 -51	-16%	-$130K	0.03%	164
2016 Q4	$960K	Buy	317 +9	+3%	+$36.3K	0.06%	149
2016 Q3	$1.69M	Buy	+308	New	+$2.16M	0.06%	144

Other funds holding AIM

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

Sabby Management's AIM Position: Q4 2025 in Review

Sabby Management sold out of AIM ImmunoTech (AIM) in Q4 2025, closing a stake of 28,884 shares — an estimated $79.1K sold.

Sabby Management first reported a position in AIM in Q3 2016 and held it in 10 quarters. The position peaked at $1.69M in Q3 2016. 13 funds tracked by Wall St. Rank hold AIM as of Q4 2025.

Sabby Management reported no remaining AIM ImmunoTech position as of Q4 2025 after selling out during the quarter.
Sabby Management sold 28,884 AIM ImmunoTech shares in Q4 2025, an estimated $79.1K.
Sabby Management first reported a position in AIM ImmunoTech in Q3 2016 and held it in 10 quarters.
Sabby Management's AIM ImmunoTech position peaked at $1.69M in Q3 2016.
13 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q4 2025.

Based on Sabby Management's 13F filing for Q4 2025, filed 17 Feb 2026.